Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidermoid Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04811027
What this trial is testing

Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC

Who this might be right for
HNSCC
Immutep S.A.S. 171
Testing effectiveness (Phase 2)UnknownNCT03927495
What this trial is testing

KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 100
Large-scale testing (Phase 3)Enrolling By InvitationNCT07311057
What this trial is testing

Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy

Who this might be right for
SCC - Squamous Cell CarcinomaSCC - Squamous Cell Carcinoma of SkinInoperable Disease
Daryoush Hamidi Alamdari, PhD 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05054439
What this trial is testing

A Clinical Study of SI-B001 in Combination With Paclitaxel/Docetaxel in the Treatment of Recurrent and Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 45
Early research (Phase 1)Study completedNCT03547388
What this trial is testing

Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on the Tumor Microenvironment

Who this might be right for
Head and Neck NeoplasmsRecurrence Tumor
Charite University, Berlin, Germany 10
Testing effectiveness (Phase 2)Ended earlyNCT00982696
What this trial is testing

Treatment of Advanced Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Milton S. Hershey Medical Center 5
Not applicableUnknownNCT05900583
What this trial is testing

Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.

Who this might be right for
Minimal Residual DiseaseEsophageal Squamous Cell Carcinoma
Guangdong Provincial People's Hospital 50
Not applicableUnknownNCT05633641
What this trial is testing

Peripheral Blood Neoantigen Specific T Cells Predict the Efficacy of Immunotherapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06861894
What this trial is testing

Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhigang Li 164
Testing effectiveness (Phase 2)Looking for participantsNCT06718205
What this trial is testing

Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University 112
Not applicableUnknownNCT03053661
What this trial is testing

Immune Response Evaluation to Curative Conventional Therapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University of Ulm 22
Testing effectiveness (Phase 2)Looking for participantsNCT07668154
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC Participants

Who this might be right for
HNSCC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Ended earlyNCT01606566
What this trial is testing

Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.

Who this might be right for
Recurrent Head and Neck CancerCarcinoma, Squamous Cell of Head and Neck
PCI Biotech AS 26
Testing effectiveness (Phase 2)Looking for participantsNCT05726370
What this trial is testing

Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck CancerResectable Head and Neck Squamous Cell Carcinoma+2 more
Dana-Farber Cancer Institute 28
Testing effectiveness (Phase 2)Study completedNCT04356170
What this trial is testing

Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma

Who this might be right for
Cancer of Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou 105
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07191977
What this trial is testing

Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamour Cell Cancer
West China Hospital 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07677475
What this trial is testing

MRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive, Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Dongguan People's Hospital 65
Early research (Phase 1)Study completedNCT00004257
What this trial is testing

Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer

Who this might be right for
Esophageal Cancer
Albany Medical College
Early research (Phase 1)Ended earlyNCT05576077
What this trial is testing

TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerUveal Melanoma+3 more
Turnstone Biologics, Corp. 31
Large-scale testing (Phase 3)Active Not RecruitingNCT02466971
What this trial is testing

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Who this might be right for
Advanced Vaginal AdenocarcinomaAdvanced Vaginal Adenosquamous CarcinomaAdvanced Vaginal Squamous Cell Carcinoma+18 more
National Cancer Institute (NCI) 450
Next Page